Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | HTR2A | P28223 | 3/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PAM | P19021 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1899986 | 0.80 | TRPA1 (0.38) | IDO1MEN1KMT2ARELAKDM4E | |
| SCHEMBL3801957 | 0.73 | IDO1 (0.43) | IDO1HTR2AMMP1MMP9MMP13 | |
| SCHEMBL23919129 | 0.72 | HTR2A (0.48) | IDO1HTR2AMMP1MMP9MMP13 | |
| SCHEMBL11048026 | 0.72 | HTR2A (0.48) | IDO1HTR2AMMP1MMP9MMP13 | |
| SCHEMBL10682846 | 0.72 | MAOB (0.44) | MEN1KMT2ANPC1RAB9ATDP1 | |
| SCHEMBL770392 | 0.72 | MAOB (0.44) | MEN1KMT2ANPC1RAB9ATDP1 | |
| SCHEMBL19548024 | 0.69 | RELA (0.43) | IDO1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL29566039 | 0.69 | IDO1 (0.55) | IDO1HTR2AMEN1KMT2APAM | |
| SCHEMBL7395933 | 0.69 | IDO1 (0.55) | IDO1HTR2AMEN1KMT2APAM | |
| SCHEMBL7395928 | 0.69 | IDO1 (0.55) | IDO1HTR2AMEN1KMT2APAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050196454-A1 | Poly(styrene-b-4-vinylphenoxyphthalonitrile) complexed with cobalt or other Group VIII metals; protective coatings | VIRGINIA POLYTECHNIC INSTITUTE & STATE UNIVERSITY | 2005-09-08 | — | — | US | claimed |
| US-20050196454-A1 | Poly(styrene-b-4-vinylphenoxyphthalonitrile) complexed with cobalt or other Group VIII metals; protective coatings | VIRGINIA POLYTECHNIC INSTITUTE & STATE UNIVERSITY | 2005-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050196454-A1 | Poly(styrene-b-4-vinylphenoxyphthalonitrile) complexed with cobalt or other Group VIII metals; protective coatings | PPOX, PARN, PRNP | IDO1 2594/4885HTR2A 4812/4885MMP1 4661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.